PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » Tests on Popular CBD Products Show Misleading Labels & High Levels of Dangerous Chemicals

Tests on Popular CBD Products Show Misleading Labels & High Levels of Dangerous Chemicals

by PublicWire
April 26, 2019
in Medical
Reading Time: 1 min read
0

It’s no surprise that CBD brands are now on everyone’s mind. Used in a variety of products ranging from cupcakes to face masks and so on, the CBD market is growing every day, and it’s estimated that it will be worth more than $16 billion by 2025.

Despite the growth of the CBD market and increased usage of CBD products, there is one underlying problem that most people are unaware of; most CBD products contain very little, or no CBD after all. This was discovered through an extensive analysis of many CBD products by leading California cannabis testing company, CannaSafe Laboratories.

Results from the analysis revealed that only about 15 percent of the products tested matched what their label claimed. In addition, most of the products contained toxic gases which could be harmful when they’re heated, vaporized or inhaled.

Analysts suggest that the reason for these alarming occurrences can be attributed to the high demand for cannabis products, and in a bid to accelerate production, most brands bypass specific processes and use substandard materials.

CannaSafe CEO Aaron Riley aired his distaste with the results of the test. “I was surprised about the results, and I was shocked to see only 15 percent pass.”

However, with more regulations coming about in regards to what can and cannot be in cannabis products, and also mandating CBD products to be thoroughly tested in accredited labs, there is hope that more companies will have no choice than to abide by the rules.

Previous Post

Presto Gets $30M to Launch its Restaurant AI

Next Post

Trump’s Block On US-China Trade Stalls Global Stocks

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Medical

FDA advisory panel recommends Moderna, Johnson & Johnson vaccine booster shots

October 18, 2021
0
Medical

Walgreens invests $5.5B to accelerate new healthcare business segment

October 18, 2021
0
Medical

Mayo Clinic to study respiratory muscle training as long COVID treatment

October 18, 2021
0
Medical

Anthem, Providence tap Vim for value-based care platform deployment

October 25, 2021
0
Medical

Healthcare lost 17,500 jobs in September amid ongoing labor shortage

October 25, 2021
0
Medical

Cigna divests life, accident and supplemental benefits businesses for $5.75B

October 25, 2021
0
Next Post

Trump's Block On US-China Trade Stalls Global Stocks

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.